NICOLE GRIFFIN: Open Payments
NPI 1578960118 · PENNSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 3 | $45 |
| ALK-Abello, Inc | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Alexion Pharmaceuticals, Inc. | 1 | $32 |
| Corium, LLC | 2 | $28 |
| SANOFI PASTEUR INC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
Products named: Jornay PM, NEFFY, GARDASIL 9, Azstarys, MENQUADFI, BEXSERO, ZORYVE.
Industry payments across PA — which companies pay providers there.
